Sign in

CIK 0001472012 · Non-accelerated filer

Immunome Inc.

Sign in to watch
Ticker
IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770694340
Phone
610-321-3700
Business address
18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$334,224
in 1 filing, $334K under 10b5-1 plans

Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Higgins Jack −$334K Chief Scientific Officer sold 17% of stake

Reading 56 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-11 Higgins Jack Chief Scientific Officer Option exercise 10b5-1 +18,000 $1.35 $24K 78,250
2026-09-11 Higgins Jack Chief Scientific Officer Sale 10b5-1 −13,200 $25.32 $334K 65,050
2026-09-11 Higgins Jack Chief Scientific Officer Gift 10b5-1 −8,800 56,250
2026-09-11 Higgins Jack Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 +18,000 133,840
2026-08-12 Barchas Isaac Director Sale 10b5-1 −11,048 $27.25 $301K 92,211
2026-08-11 Barchas Isaac Director Sale 10b5-1 −62,291 $26.23 $1.6M 0
2026-08-10 Barchas Isaac Director Sale 10b5-1 −10,125 $26.07 $264K 62,291
2026-08-07 Barchas Isaac Director Sale 10b5-1 −15,248 $26.06 $397K 72,416
2026-08-06 Barchas Isaac Director Sale 10b5-1 −20,840 $26.06 $543K 87,664
2026-08-04 Horn Kinney CHIEF BUSINESS OFFICER Option exercise 10b5-1 +50,366 $12.92 $651K 50,366
2026-08-04 Horn Kinney CHIEF BUSINESS OFFICER Option exercise 10b5-1 +40,250 $10.60 $427K 90,616
2026-08-04 Horn Kinney CHIEF BUSINESS OFFICER Sale 10b5-1 −90,616 $25.09 $2.3M 0
2026-08-04 Horn Kinney CHIEF BUSINESS OFFICER Option exercise · Employee Stock Option (right to buy) 10b5-1 −50,366 78,542
2026-08-04 Horn Kinney CHIEF BUSINESS OFFICER Option exercise · Employee Stock Option (right to buy) 10b5-1 −40,250 120,750
2026-07-23 Tsai Philip Chief Technical Officer Grant or award +38,250 81,550
2026-07-23 Tsai Philip Chief Technical Officer Grant or award · Employee Stock Option (right to buy) +76,500 76,500
2026-07-23 Lechleider Robert Chief Medical Officer Grant or award +54,000 69,805
2026-07-23 Lechleider Robert Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +108,000 108,000
2026-07-23 Rosett Max Chief Financial Officer Grant or award +47,250 101,287
2026-07-23 Rosett Max Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +94,500 94,500

Page 1 of 8 · 159 trades